At the end of the cell cycle, cyclin-dependent kinase (CDK) activity is inactivated to allow mitotic exit [1] . A protein phosphatase, Cdc14, plays a key role during mitotic exit in budding yeast by activating the Cdh1 component of the anaphase-promoting complex to degrade cyclin B (Clb) and inducing the CDK inhibitor Sic1 to inactivate Cdk1 [2]. To prevent mitotic exit when the cell cycle is arrested at G2/M, cells must prevent CDK inactivation. In the spindle checkpoint pathway, this is accomplished through Bfa1/Bub2, a heteromeric GTPase-activating protein (GAP) that inhibits Clb degradation by keeping the G protein Tem1 inactive [3] [4] [5] . Tem1 is required for Cdc14 activation. Here we show that in budding yeast, BUB2 and BFA1 are also required for the maintenance of G2/M arrest in response to DNA damage and to spindle misorientation. cdc13-1 bub2 and cdc13-1 bfa1 but not cdc13-1 mad2 double mutants rebud and reduplicate their DNA at the restrictive temperature. We also found that the delay in mitotic exit in mutants with misoriented spindles depended on BUB2 and BFA1, but not on MAD2. We propose that Bfa1/Bub2 checkpoint pathway functions as a universal checkpoint in G2/M that prevents CDK inactivation in response to cell-cycle delay in G2/M. 
Results and discussion
Cdc13 is a telomere-binding protein that protects telomeres. At the restrictive temperature, cdc13-1 mutants accumulate single-stranded DNA and arrest as large budded cells with short spindles through the DNA damage checkpoint [6] [7] [8] . In the presence of DNA damage, Rad53 is required to maintain high CDK activity and prevent mitotic exit [9, 10] . Similarly, the Bfa1/Bub2 branch of the spindle checkpoint is required to maintain high CDK activity in response to spindle damage [5, 11] . Thus, we asked whether Bub2/Bfa1 has a role in the DNA damage checkpoint. We examined the phenotype of mad1, mad2, bub2, and bfa1 mutants in a cdc13-1 background. Cells arrested with α-factor were released into YPD media at 34°C, the restrictive temperature for cdc13-1. After 5 hours, more than 60% of the double mutants between cdc13-1 and bub2, bfa1 showed rebudding and re-replication, whereas the cdc13-1 single or cdc13-1 mad1, cdc13-1 mad2 double mutants arrested as large budded cells and failed to re-replicate (Figure 1a-c) . All cdc13, bub2, bfa1 mutant combinations failed to undergo anaphase as judged by spindle elongation and chromosome segregation. Consistent with this, the level of Pds1, an anaphase inhibitor, in cdc13-1 bub2 and cdc13-1 bfa1 cells stayed as high as that in cdc13-1 single mutant cells (Figure 1e ). This mitotic exit phenotype works through activation of the standard mitotic exit network because it is dependent upon the G protein Tem1 (Figure 1d ). Mitotic exit generally requires either Clb degradation or SIC1 induction. Consistent with this, cdc13 bub2 bfa1 mutants, but not cdc13 mutants alone, induce Sic1 protein in sychronized cells released from G1 arrest at the restrictive temperature for cdc13. Furthermore, overexpression of the CDK inhibitor SIC1 results in CDK inactivation and mitotic exit in cdc13-1 mutants, indicating that cellcycle arrest requires high CDK activity (Figure 1f ). These observations indicate that Bub2 and Bfa1 are required to prevent mitotic exit, but are not required to prevent sister chromatid separation in response to DNA damage.
Given its role in the DNA damage checkpoint, we hypothesized that Bfa1/Bub2 might be required for preventing mitotic exit for all mutants that arrest in G2/M with high CDK activity, including the spindle misorientation mutants. Thus, we examined the role of Bub2 in jnm1 and act5 mutants. Jnm1, Act5 and Nip100 localize on the cytoplasmic surface of the spindle pole body (SPB) and are required for entry of the SPB into the daughter cell [12] . jnm1, nip100, act5 mutants display defects in mitotic spindle orientation, resulting in some large-budded cells with two nuclei in the mother cell. In the cold, the mutant cells have a more severe spindle misorientation phenotype [12] [13] [14] [15] that is corrected before cytokineses by a cell-cycle delay. We tested if the spindle assembly checkpoint genes were required for cell-cycle delay in these mutants by making double mutants between jnm1 or act5 and bub2, bfa1, or mad2. All double mutants we obtained were viable at room temperature. Unlike their mad2 counterparts, act5 bub2, act5 bfa1, jnm1 bub2 and jnm1 bfa1 double mutants were cold sensitive (Cs) for growth (Figure 2a ).
To examine whether the enhanced Cs phenotype is due to a failure to arrest, we examined cells grown on YPD plates at 16°C for accumulation of multiple nuclei. A significant percentage of act5 bub2, act5 bfa1, jnm1 bub2, and jnm1 bfa1 double mutants, but not mad2 double mutants, contained extra nuclei or no nuclei, indicating a failure in cell-cycle delay and execution of cytokinesis without nuclear segregation (Figure 2b ).
To further address the checkpoint defect, log-phase cells grown at 30°C were arrested with α-factor and released into YPD at 16°C. Hydroxyurea (200 mM) was added to the medium at 3.5 hours after release to block the second S phase. Most cells complete the first S phase by 3.5 hours. At time 0, approximately 10% of jnm1 cells were large budded, presumably resulting from the spindle misorientation defect in the previous cycle. We observed a significant accumulation of cells with greater than two buds in (Figure 2c,d) . As the spindle misorientation phenotype has a relatively low penetrance, the observed percentage of rebudding actually represents a significant checkpoint defect. The lower panel in Figure 2c shows the percentage of small-budded cells as a measure of cellcycle progression. The timing of rebudding of jnm1 bfa1 or jnm1 bub2 double-mutant cells coincided with the time that wild-type cells began to bud during the second cell cycle, indicating that the double-mutant cells with misoriented spindles rebudded with virtually no delay. In contrast, the rebudding kinetics in bfa1 or bub2 mutant cells in cdc13-1 mutant background or in the presence of nocodazole was delayed compared with the undisturbed cell cycle (data not shown). One possible explanation for this difference is that the DNA damage and spindle checkpoint pathways have Bfa1/Bub2-independent branches preventing mitotic exit, whereas the delay caused by misorientation of spindles relies solely on Bfa1 and Bub2. We conclude that the synthetic phenotype between bub2, bfa1 and jnm1, act5 results from the inability of the double mutants to maintain the cell cycle delay in response to spindle misorientation.
In the mitotic exit pathway, Bub2 and Bfa1 act as a GAP for the G protein Tem1, whose activation leads to the delocalization of Cdc14 from the nucleolus [5, 16, 17] . The absence of Bfa1/Bub2 results in an inability to maintain cell-cycle arrest in response to DNA damage, spindle disruption or spindle misorientation. Instead, cells rebud and reduplicate their DNA. Thus, we examined the localization of Cdc14 in various mutants. cdc13-1 and cdc13-1 bub2 bfa1 cells containing a CDC14-HA construct encoding hemagglutinin (HA)-tagged Cdc14 were synchronized with α-factor and released into YPD medium at 34°C. Cdc14 localization was examined 4 hours after release. Whereas cdc13-1 mutant cells showed nucleolar Cdc14 localization, we observed a significant percentage of cells with delocalized Cdc14 in cdc13 bub2 bfa1 mutant cells (Figure 3a) . Thus Bub2 and Bfa1 are required to prevent Cdc14 release when cells were arrested at G2/M with damaged DNA.
Cdc14 localization in wild-type and bfa1 cells arrested with nocodazole was also examined. CDC14-HA and bfa1 CDC14-HA cells were synchronized with α-factor and released into YPD medium containing 10 µg/ml nocadozole at 30°C. During the first 60 minutes after release, both wild-type and bfa1 cells showed nucleolar Cdc14 localization. By 80 minutes, however, only bfa1 mutants showed Cdc14 delocalization (Figure 3b,c) . Thus bfa1 mutants fail to maintain nucleolar localization of Cdc14 in the presence of nocodazole. Consistent with this, Cdc14 was delocalized in binucleate jnm1 bub2 and jnm1 bfa1 mutants grown at 25°C but not jnm1 mad2 or jnm1 mutants (Figure 3d,e) . These findings strongly argue that the Bfa1/Bub2 checkpoint pathway negatively regulates the mitotic exit network by keeping Cdc14 in the nucleolus, and that this checkpoint is required for the cell-cycle arrest in different stages during G2/M.
The fact that cdc13 bub2 mutants and nocodazole-treated bub2 mutants still show a delay in budding indicates that Brief Communication 1381 there is more than one mechanism for delaying mitotic exit (Figure 3f ). One explanation for this additional pathway involves Clb5 and Pds1. cdc20 clb5 and cdc20 pds1 double mutants fail to exit mitosis whereas cdc20 pds1 clb5 triple mutants can exit, indicating that both Pds1 and Clb5 play negative roles in mitotic exit [18] . The presence of Clb5 and Pds1 in cdc13-1-and nocodazole-arrested cells may contribute to the delay in rebudding despite the absence of the Bfa1/Bub2 checkpoint. In contrast, the cell-cycle delay in jnm1 and act5 mutants occurs in late anaphase, when Pds1 and Clb5 have already been degraded. Thus, Bfa1/Bub2 may be solely responsible for the cell-cycle delay in response to spindle misorientation (Figure 3f ).
In conclusion, we have shown that Bub2/Bfa1 is required to prevent Cdc14 delocalization, rebudding and DNA rereplication in response to spindle damage, DNA damage or spindle misorientation. How Bfa1 and Bub2 are regulated by these different types of stress remains to be seen. It is possible that they are not regulated per se, but merely set up a dependency for the function of guanine-nucleotide exchange factors such as Lte1 to operate upon Tem1-GDP to activate mitotic exit. Thus, under normal conditions, it may be Lte1 that is regulated or the association of Tem1 with Lte1, as recently suggested [19] . The regulation of Bfa1/Bub2 remains to be elucidated.
Materials and methods

Yeast strains and media
All strains used in this study are isogenic with the W303-derived Y300 strain. ∆bub2::URA3 was constructed by transplacement using plasmid pTR24 provided by M.A. Hoyt (Johns Hopkins University). ∆bfa1::his5 was constructed using a PCR-based gene disruption method [20] . All other stains are constructed by standard genetic cross. Yeast was grown in YPD medium unless otherwise mentioned.
Cytological techniques
FACS analysis was performed as previously described [17] . Immunofluorescence microscopy using anti-HA antibodies was done after formaldehyde fixation as described [9] . Cells were fixed by 5% formaldehyde for 0.5 h and then stained by anti-HA monoclonal antibody (1:200 dilution, Santa Cruz) after methanol/acetone treatment. DAPI was used to stain DNA after fixation.
